Erin Brown

5 statements · 3 topics

Nothing matches these filters — clear the search or widen the filters.

Erin's statements about High-risk Neuroblastoma 2 statements

Open the High-risk Neuroblastoma collection →

Dr. Yujie Ma - Best of the Best in Pediatric Surgery 2025

▶ Ep 3 · 5:58

quote how universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies. ↗

▶ Ep 3 · 5:58

quote how universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies. ↗

Erin's statements about Neuroblastoma 2 statements

Open the Neuroblastoma collection →

Dr. Yujie Ma - Best of the Best in Pediatric Surgery 2025

▶ Ep 18 · 5:58

quote how universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies. ↗

▶ Ep 18 · 5:58

quote how universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies. ↗

Erin's statements about Pediatric Oncology 1 statement

Open the Pediatric Oncology collection →

Dr. Yujie Ma - Best of the Best in Pediatric Surgery 2025

▶ Ep 555 · 5:58

quote how universal is this down-regulation of CAMK2G across neuroblastoma cells? As you mentioned, it's really heterogeneous, and so that's a problem when developing these targeted therapies. ↗